α1-antitrypsin deficiency·5: Intravenous augmentation therapy: Current understanding

44Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

The biochemical and clinical efficacy of intravenous augmentation therapy in α1-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.

Cite

CITATION STYLE

APA

Stoller, J. K., & Aboussouan, L. S. (2004, August). α1-antitrypsin deficiency·5: Intravenous augmentation therapy: Current understanding. Thorax. https://doi.org/10.1136/thx.2003.006544

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free